Literature DB >> 6099127

Cefotaxime: sites and pathway of metabolic conversion.

C M Macdonald, A McDonald, J M Fromson, J D Coombes.   

Abstract

This paper examines the metabolism of 14C-cefotaxime (14C-HR 756) in the rat and attempts to identify the metabolic events in this and other species. In rat desacetyl cefotaxime is usually the major excretion product and sole metabolite of cefotaxime. However, when renal elimination of this metabolite is prevented by bilateral nephrectomy, two further metabolites, the stereoisomeric opened beta-lactam ring forms of desacetyl cefotaxime lactone, are also produced. These metabolites are found in the urine of man and dogs dosed with cefotaxime. It is suggested that generation of these metabolites is dependent on formation of the lactone form of the desacetyl metabolite. Evidence is also presented showing that these metabolic conversions occur in the liver.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6099127

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  2 in total

1.  Metabolic disposition of DQ-2556, a new cephalosporin, in rats, rabbits, dogs, and monkeys.

Authors:  K Matsubayashi; S Shintani; M Yoshioka; H Tachizawa
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

2.  Investigation of the biliary clearances of cefotaxime and desacetylcefotaxime by an original procedure in cholecystectomised patients.

Authors:  F Jehl; J D Peter; A Picard; J P Dupeyron; J Marescaux; A Sibilly; H Monteil
Journal:  Infection       Date:  1987 Nov-Dec       Impact factor: 3.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.